Gregory A. Bonfiglio

Gregory A. Bonfiglio

Board Member at ImmuneBridge Inc.

Are you Gregory A. Bonfiglio? Claim your profile
 
  • IDENTIFY executive and board member connections in Gregory A. Bonfiglio's network.
  • FOLLOW changes in Gregory A. Bonfiglio's employment.
  • CONNECT with Gregory A. Bonfiglio through your network of contacts.

Gregory A. Bonfiglio's Executive Work History


Current
Board Member,
Board Member
Equilar on 01/10/2023
ImmuneBridge Inc.
Board Member,
Board Member
Equilar on 10/04/2022
Centre for Commercialization of Regenerative Medicine (CCRM)
Advisor,
Advisor
Equilar on 05/18/2023
BIOBRIDGE GLOBAL
Past
To view Gregory A. Bonfiglio's complete executive work history,
Age
71
 

Gregory A. Bonfiglio's Biography


He is the Chairman of the Board of the Centre for Commercialization of Regenerative Medicine in Toronto, Canada. Bonfiglio serves on the Board of Healios KK, one of the largest publicly traded regenerative medicine companies in Japan. In addition, he has served on the boards of several other regenerative medicine companies, including VistaGen Therapeutics (in vitro tools from hESCs); Advanced Cell Technologies (hESC therapeutics); California Stem Cell (hESC tools and therapeutics); and StemCyte, Inc. (cord blood storage and therapeutics). Bonfiglio was an early investor in the field of stems cell and regenerative medicine, and he continues to be actively involved in the field. He is a frequent speaker at regenerative medicine conferences and is a member of the ISSCR, as well as serving on its advisory board, as well as its Finance Committee. He also is a member of the ISCT. In 2013, Bonfiglio was listed 14th among the Top 50 Stem Cell Influencers in the world. He has more than 25 years’ experience working with technology companies. From 2000-05, Bonfiglio was a General Partner with Anthem Venture Partners – an early stage venture fund in California. While at Anthem, Bonfiglio led investments in both biotechnology and IT. Prior to joining Anthem, he was a Partner with Morrison & Foerster, where he worked extensively with technology clients. Bonfiglio was an Adjunct Professor of Law at Stanford Law School from 1996-2000. He has been a Guest Lecturer at the Stanford Business School on the Commercialization of Regenerative Medicine Technologies. From 1995-2005, he was a regular Guest Lecturer at the UC Berkley Haas Business School in the Entrepreneurship Program. Bonfiglio received his bachelor of arts degree in Mathematics (magna cum laude) from Michigan State University in 1975, and his J.D. (magna cum laude) from the University of Michigan Law School in 1981.

Source: BIOBRIDGE GLOBAL on 05/18/2023

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Gregory A. Bonfiglio. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Gregory A. Bonfiglio's network.
  • FOLLOW changes in Gregory A. Bonfiglio's employment.
  • CONNECT with Gregory A. Bonfiglio through your network of contacts.
 

Access over 2,000,000 executive and board member profiles.

Example: Gregory A. Bonfiglio

Gregory A. Bonfiglio's Connections (42)


Glenn Kues
Former Senior Vice President and Chief Financial Officer, BIOBRIDGE GLOBAL
John Youngdahl
Senior Vice President and Chief Financial Officer, BIOBRIDGE GLOBAL
Martin J. Landon
Chairman And Treasurer and Director, Renovo Concepts, Inc.
Jerrold Duane Dotson
Former Vice President and Chief Financial Officer, Vistagen Therapeutics, Inc.
Vivek Goel
Board Member, Centre for Commercialization of Regenerative Medicine (CCRM)
Duncan Stewart
Board Member, Centre for Commercialization of Regenerative Medicine (CCRM)
Cynthia Lavoie Ph.D.
President and Chief Investment Officer, CCRM Enterprises Ltd., Centre for Commercialization of Regenerative Medicine (CCRM)
Alicia Jackson
Board Member, ImmuneBridge Inc.
Gail K. Naughton Ph.D.
Director, CEL-SCI Corporation
Dylan Morris
Managing Director, Insight Partners